The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss BPC 157: The peptide with big claims and scant evidence STAT